QUAADIR OTTO-SMALLWOOD: Open Payments
NPI 1447871389 · HERSHEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$45,276 in 121 payments from 7 companies in 2025. Trend: 2023 $620 · 2024 $16,964 · 2025 $45,276
Speaker / faculty: $35,497Travel & lodging: $5,603Food & beverage: $3,020Consulting: $1,156
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 103 | $44,012 |
| Celltrion USA Inc. | 10 | $517 |
| ABBVIE INC. | 3 | $302 |
| PFIZER INC. | 1 | $189 |
| Johnson & Johnson Health Care Systems Inc. | 1 | $133 |
| Janssen Scientific Affairs, LLC | 2 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: TREMFYA, STELARA, ZYMFENTRA, VELSIPITY, VEGZELMA, CREON, SKYRIZI, RINVOQ.
Industry payments across PA — which companies pay providers there.
